Price: $77.8
· 1 day: -0.87% · 5 days: +7.83% · 1 month: +1.53% · YTD: +31.75%
As of 2026-11-03 21:00 UTC.
52-week range: $40.77 – $89.09 (currently at 77% of the range).
TEM is in an uptrend, momentum firm. $80 is the level overhead; $72.98 the first support below.
6 of 6 technical checks lean bullish.
| Trend | Uptrend · above 50-day & 200-day |
|---|---|
| Momentum | RSI 60.66 · neutral · MACD bullish |
| Trend strength | ADX 19.1 · weak or range |
| Location | +9.5% vs 50-day MA |
| 52-week range | -12% from high · +87% from low |
| Volatility | ATR 6.4 · ~8.2%/day |
| Level | Type | Distance |
|---|---|---|
| $80.0 (resistance) | round | 2.83% |
| $88.71 (resistance) | 52w high | 14.02% |
| $90.0 (resistance) | round | 15.68% |
| $72.98 (support) | swing zone | -6.2% |
| $71.04 (support) | sma 50 | -8.69% |
| $70.0 (support) | round | -10.03% |
| RSI (14) | 60.66 | MACD | 1.367 |
|---|---|---|---|
| ADX (14) | 19.1 | ATR (14) | 6.4 |
| 50-day average | $71.04 | 200-day average | $57.02 |
Next earnings: 2026-11-02. TEM earnings date, time and past reactions.
Report of 2026-10-28, updated 2026-11-02.
Tempus AI (TEM) surged 11.4% on November 2, 2026, after reporting Q3 revenue of $411.5 million (up 23% YoY) and narrowing its net loss to $14.9 million, per its SEC filing. The stock is up 19.8% over five days, versus a 0.3% decline in SPY and a 2.5% gain in XLV, extending its 50-day outperformance of both (+14.3% vs SPY, +6.3% vs XLV).
The picture holds. The price at $80.47 remains above the 80.0 round support and the 50-day SMA (70.84), with the weekly uptrend intact. The 5-day move has pushed RSI to 63.35, but volume is 12.8% below its 20-day average, so the breakout above 89.85 (52-week high) has not yet been confirmed on strong volume. The first crack below 80.0 would signal weakness, and a weekly close below 70.84 would change the picture. The next earnings date has passed, and the analyst consensus target ($75.06) is now 7.2% below the current price.
Resistance stands at 89.85 and 100.0, with support at 80.0, 72.98, and 70.84. The stock is 10.4% below its 52-week high and 93.7% above its low.
Tempus AI (TEM) jumped 7.4% in a single day to $72.15, recovering part of a slide that had taken it 15.2% below its September 28, 2026 peak. The weekly trend is still up and the daily trend runs with it, so the balance of evidence leans positive for the next 2–6 weeks, with medium conviction. Earnings on November 2, 2026 are the next test. A daily close above $72.98 on heavier volume would be the first sign that buyers are back.
The move is the story, and the news does not explain it. No company announcement, deal or analyst action sits behind the 7.4% one-day jump, and nothing in the debate around the stock points to a cause. The honest reading is that this is a price-driven rebound after a sharp drop, not a reaction to new information. That matters because rebounds without a catalyst tend to be tested quickly.
The size of the earlier fall shows what was priced in. From the September 28 close of $85.08 the shares lost 15.2%, and over the past month they are down 15.1%. Over six months they are still up 37%, and year to date they are up 22.2%. The stock has given back a large part of a strong run and has now recovered a slice of that loss. Its price is about 21.2% below the 52-week high of $91.58 and 73.7% above the low of $41.55.
Almost none of the latest five-day gain came from the market or the sector. The stock rose 8.1% over five days, while the S&P 500 (SPY) added just 0.08% and the healthcare sector fund XLV fell 0.36%. That leaves about 8.4 points of outperformance against the sector that belong to TEM alone. Over 50 days TEM leads the S&P 500 by 3.2 points but trails XLV by 1.0, so the longer record is one of a stock moving roughly with its sector, not away from it. Over 200 days it leads the market by 20.2 points.
No articles are available to set out the debate between bulls and skeptics, so the argument can only be inferred from the numbers. The 18 analysts covering the stock rate it a buy, with a mean price target of $75.06. Targets range from $35.00 to $100.00, a very wide spread that shows how little agreement there is on what the business is worth. At $72.15 the shares sit 3.9% below the mean target, so the consensus sees limited room on its own numbers, and the upside case rests on the high end of that range. The market value is about $13.1 billion.
On the long term the thesis is intact but has been tested. Price is above its 40-week average, and the 50-day average at $69.7 is well above the 200-day at $56.83. That is an established uptrend in a correction phase: the stock peaked in late September, fell hard, and is now trying to rebuild. Nothing in the weekly structure is broken.
For the next 2–6 weeks the balance of evidence leans positive, and conviction is medium, 2 of 4 points. Two things support it: the daily trend runs with the weekly uptrend, and the stock leads the S&P 500 over 50 days. The other two points are missing, which is why conviction is not higher. RSI is 52.8, which is neutral and gives no oversold or momentum signal. Volume on the latest session was 18.1% below its 20-day average, so the jump came without heavy participation.
The strongest case against this reading is exactly that thin participation, together with the lag against XLV. The stock trails its sector by 1.0 point over 50 days, which is against the trend, and a 7.4% one-day jump on below-average volume is the kind of move that can fade. It does not tip the balance because price is holding above the 50-day average and the weekly trend is intact. It does cap conviction at medium until volume confirms.
The structure holds above $70.0, a round number that sits next to the 50-day average at $69.7. A first crack comes below $70.0. The trend itself ends below $61.79, a swing zone that also sits above the round $60.0 and the next support at $57.88. The ATR is $5.18, so a typical daily swing is large relative to the distance between $70.0 and the current price.
The breakout level is a daily close above $72.98 on volume above its 20-day average. From there the math points to the 52-week high of $91.58, with $80.00 and $90.00 as resistance on the way. The breakout would be wrong below $68.70, which is $70.0 minus a quarter of ATR. Against that stop the target gives a reward-to-risk of 4.3 to 1, which clears the 3 to 1 that makes a breakout worth the risk.
A weekly close below $61.79 would change the picture, because it would break the swing zone that defines the end of the uptrend and put price under the lows of the current correction. The non-price fact that would do it is earnings: a result that forces a reset of expectations, with the stock already well off its highs, would be the likeliest trigger. A clean result that holds the rebound would instead strengthen the positive reading.
Interactive TEM chart and analyst chat · Market terminal — movers, signals and news · Use MarketCrew inside Claude · Use MarketCrew inside ChatGPT · Top gainers today · 52-week highs